ArticleCureus2026
Givosiran for the Treatment of Hereditary Coproporphyria in Pregnancy: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hereditary coproporphyria (HCP) is a rare autosomal dominant disorder of heme synthesis characterized by acute neurovisceral attacks that are often precipitated by exposure to medications or hormones. Patients with HCP who become pregnant have an elevated risk of more frequent neurovisceral attacks and other obstetric complications. Givosiran, a small interfering RNA therapeutic, is considered the gold-standard prophylactic treatment for acute hepatic porphyrias, but its use has not been studied during pregnancy. We describe our patient who successfully continued givosiran throughout pregnancy. This highlights the role of shared decision-making in managing medically complex patients during pregnancy when treatment data may be limited or non-existent and the need for further investigation into the safety profile of givosiran use in pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.